Chronic Pain Common Among Returning Soldiers

Published Online: Monday, August 4, 2014
Follow Pharmacy_Times:
A substantial number of US soldiers returning home experience chronic pain, and many of them use opioid painkillers to cope, according to the results of a recent report published online on June 30, 2014, in JAMA Internal Medicine.

Members of an Army infantry brigade completed confidential surveys in 2011, 3 months after coming home from Afghanistan or Iraq. Soldiers who reported pain duration of 3 or more months were considered to have chronic pain.

Of the 2597 soldiers who completed the survey, 44% experienced chronic pain and approximately 15% said they had used opioids in the past month, compared with 26% of civilians who experience chronic pain and 4% who use opioids. Among those who reported using opioids, 62.6% only used the painkillers for a few days. Combat injuries were the main risk factor for both chronic pain and past-month opioid use, and 45.4% of soldiers reported injuries. Other risk factors for chronic pain included age of 30 years or older, current or previous marriage, medium or high levels of combat exposure, and screening positive for posttraumatic stress disorder or major depression.

Among those who did report chronic pain, 48.3% indicated that they had experienced the pain for a year or more, and 55.6% said their pain occurred daily or constantly. Approximately 80% reported using OTC pain medications, 19% used nonopioid prescription painkillers, and 23% used opioids.

Related Articles
Mylan Inc. has introduced 3 generic versions of existing drugs to the US market, including the first and only available intermediate dosages of transdermal fentanyl.
I distinctly remember feeling surprised when the FDA approved the first single entity and extended-release hydrocodone pain medication.
Are pharmacists fully aware of the warnings associated with the medications they dispense?
Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times